These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis. Eggink HF, Houthoff HJ, Huitema S, Gips CH, Poppema S. Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407 [Abstract] [Full Text] [Related]
3. Variations in humoral and cellular immunologic changes in relation to the evolutive stage of chronic active liver disease. Banciu T, Argan P, Suşan L, Ocică I, Perţa D. Med Interne; 1987 Oct; 25(1):25-30. PubMed ID: 3495858 [Abstract] [Full Text] [Related]
4. The interference of an autoimmune mechanism in the pathogeny of chronic active liver diseases. Banciu T, Arcan P, Văcariu V, Tudose N. Med Interne; 1989 Oct; 27(1):47-52. PubMed ID: 2749158 [Abstract] [Full Text] [Related]
6. Does the immune response play a role in the pathogenesis of chronic liver disease? Mondelli MU, Manns M, Ferrari C. Arch Pathol Lab Med; 1988 May; 112(5):489-97. PubMed ID: 3282484 [Abstract] [Full Text] [Related]
12. Cell mediated cytotoxicity to autologous hepatocytes in hepatitis B virus infection: facts, limits and relevance. Boltz-Nitulescu G, Penner E, Gangl A. Z Gastroenterol; 1985 Apr; 23(4):188-91. PubMed ID: 2414933 [No Abstract] [Full Text] [Related]
13. Membranous expression of Lewis Y antigen in clustered hepatocytes in chronic viral, autoimmune, and alcoholic liver diseases but not in biliary diseases. Sasaki M, Kono N, Nakanuma Y. Mod Pathol; 1994 Apr; 7(3):339-46. PubMed ID: 8058706 [Abstract] [Full Text] [Related]
14. Mechanisms of autoimmune liver disease. Meyer zum Büschenfelde KH, Manns M. Semin Liver Dis; 1984 Feb; 4(1):26-35. PubMed ID: 6231727 [No Abstract] [Full Text] [Related]
15. Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood. Donaldson PT, Hussain MJ, Mieli-Vergani G, Mowat AP, Vergani D. Clin Exp Immunol; 1989 Jan; 75(1):41-6. PubMed ID: 2784729 [Abstract] [Full Text] [Related]
16. [Cytotoxic activity of the lymphocytes in patients with chronic hepatitis and liver cirrhosis]. Mokhov VM, Lisok TP, Petrov AL. Ter Arkh; 1983 Jan; 55(2):43-5. PubMed ID: 6601859 [No Abstract] [Full Text] [Related]
17. [Comparative in vitro studies of cell-mediated immunity in chronic liver diseases]. Königstedt B, Zipprich R, Nilius R. Dtsch Z Verdau Stoffwechselkr; 1986 Jan; 46(2):113-21. PubMed ID: 3487441 [Abstract] [Full Text] [Related]
18. Characterization of effector cells in lymphocytotoxicity to autologous hepatocytes in HBsAg-positive and autoimmune chronic active hepatitis (CAH). Barnaba V, Levrero M, Franco A, Ruberti G, Musca A, Bonavita MS, Balsano F. Liver; 1986 Feb; 6(1):45-52. PubMed ID: 3487021 [Abstract] [Full Text] [Related]
19. [Lipid peroxidation, collagen metabolism and cellular immunity indices of patients with chronic hepatitis and liver cirrhosis]. Okorokov AN. Ter Arkh; 1988 Feb; 60(2):52-4. PubMed ID: 3259342 [Abstract] [Full Text] [Related]